chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day after vaccination (March 15, 2022): Fatigue, lightheadedness, I couldn't sleep the night after vaccination until 3 am, had a light headache and slightly blurred vision, feeling nauseous.  One week after vaccination (March 21, 2022): Fatigued, lingering/light headache, heavy and painful legs for days (like after a really intense workout), light chills, feverish, hands feel slightly shaky.  At-home covid test was negative.   Today (April 1, 2022): Still feeling weak and shaky.
Sore arm; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a elderly female patient who received Herpes zoster (Shingrix) (batch number 7AN44, expiry date 24th April 2022) for prophylaxis.   On 19th January 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional information was provided as follows: The reporter consented to follow up. For tolerance of 2nd dose, refer case US2020079540.
9FEB94 student came into office & showed RN lt arm which had a round crusted area, red with a red line encircling area aobut 1" away from lesion; This appeared 6FEB94, shot given 16FEB93; 2mo earlier;
Pt reported sweating, lightheadedness, slight pallor Vitals: 129/77, 88, 18, 96% An ammonia inhalant was used Pt was assisted to wheelchair.  Remained A&O x3.  Pt given fluids (juice and water).  Pt appeared to have recovered, skin color improved and appeared pink/warm.   Pt stable and released from the vaccination site @14:30 accompanied by mother
Mother & pt report that 20 days after receiving vaccines pt had palpitations, racing heart beat, was followed up by his physician & a cardiologist all workup done, outcome was normal & only thing doctors could find was that pt had allergic reaction to the Oral Typhoid & not be surprised if it occurs again with other vaccinations.
Got sick to my stomach, got chills, got 101 degree fever, arm was red and hot all the way to my elbow. The next day my sugar was up, and my blood pressure was low, I was still sick to my stomach for 6 days.
Pt. describes about 7 hrs after receiving vaccine developed chills, couldn't get warm, total body aches, fatigue felt as though she couldn't walk - lasted into next day, (Sat.) but did improve. States has never felt so terrible and has received many other vaccines including flu in the past.
2 month old was given Kinrix; This case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received DTPa-IPV (Kinrix) (batch number E2L54, expiry date 3rd March 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 8th August 2022, the patient received the 1st dose of Kinrix (intramuscular) .5 ml and Kinrix Pre-Filled Syringe Device. On 8th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-AUG-2022 Reporter's comment: The physician reported that the patient received a dose of Kinrix into right thigh. The patient was not experienced any side effects. The reporter did not consent to follow up. Additional Supportive Information: The two month old patient received a dose of Kinrix, which led to inappropriate age at vaccine administration.
81 y.o. male presenting with hypoxia and increased work of breathing for 2 days.  He has a 6 day history of myalgia, SOA, and increased weakness. He reports testing positive at a clinic for COVID 6 days ago. He was seen there for rhinorrhea, nasal congestion, he thought to be regular seasonal allergies, and was tested for COVID which resulted as positive, as did his wife.  His symptoms progressed and on Friday he called his PCP who gave him a Z-pack and Prednisone 20mg to take daily.  He says his respiratory status declined over the weekend and today felt as though he needed additional treatment.    Constitutional: Positive for activity change (due to SOA/hypoxia) and fatigue. Negative for appetite change, chills and fever.  HENT: Positive for sore throat (raw mouth/throat hurts to brush teeth). Negative for congestion and voice change.        Reports redness with burning noted in mouth/tongue with brushing teeth and some foods x2-3 days.  Eyes: Negative.   Respiratory: Positive for cough and shortness of breath. Negative for wheezing.    an 81 y.o. male previously vaccinated for COVID who is admitted (on 9/21) for hypoxic resp failure 2/2 COVID, diagnosed 6 days PTA. He was started on dexamethasone and remdesivir for COVID on admission. He suffered from rapidly increasing oxygen requirements and after being placed on HFNC was started on baricitinib on 9/22. His O2 requirements stabilized and he was slowly weaned off oxygen and on RA on 9/27. While acutely ill he developed frequent PVCs and was started on coreg 3.125, but was unable to be titrated up to due to bradycardia.    Discharge Disposition/Condition Disposition: Home with Home Health Condition: Stable (s/sx potential problems absent or manageable)
Pt reported the development of a small area of redness @ inject site w/in 12 hrs of receiving Tyhoid vax; red area gradually inc in size, extending from the mid-deltoid to elbow accompanied by swelling & itching; Cold packs were applied;
pt vax in 1995 & in 1999 pt devel breakthrough varicella. the following day 20feb99 the pt presented to MD w/greater than 20 lesions & fever. addl info requested.
The patient will come back when the new vaccine comes in; During reconstitution of RabAvert, diluent leaked out of the top, when the cap popped off and the diluent leaked out of the syringe; Case reference number US-BN-2021-001685 is a spontaneous case report initially received from a pharmacist via Agency (case PQC number K21-PQC025, reference number: USBAV21-0149) on 06-May-2021, and concerns a patient of an unknown demographics.  The patient's medical history and concomitant medication details were not provided.  It was stated by the reporter that during reconstitution of RabAvert (Inactivated Rabies Virus Vaccine, Batch no. not provided) diluent leaked out of the top, when the cap popped off and the diluent leaked out of the syringe (Product preparation issue). The vaccine was for pre-exposure and the patient will come back when the new vaccine comes in, as reported (Missed dose).  Information on whether the patient experienced any adverse events due to RabAvert was not provided.  Additional information received from Agency on 11-May-2021 included reporter's identifiers, original verbatim report from the reporter and it is blended in the case narrative above.  No further information was provided.; Reporter's Comments: Product dose omission issue and product preparation issue are listed by convention. Reportedly, during reconstitution of RabAvert diluent leaked out of the syringe (product preparation issue). Therefore, the patient didn't receive the dose of RabAvert which is considered missed dose. No adverse events were reported. Missed dose and product preparation issue are not related to the suspect product but to a human action.; Sender's Comments: Product dose omission issue and product preparation issue are listed by convention. Reportedly, during reconstitution of RabAvert diluent leaked out of the syringe (product preparation issue). Therefore, the patient didn't receive the dose of RabAvert which is considered missed dose. No adverse events were reported. Missed dose and product preparation issue are not related to the suspect product but to a human action.
Patient described extreme pain in her arm that vaccines were administered; no relief with pain "killers" that she takes daily due to back surgery. Patient stated she cannot sleep at night due to pain, cannot sign her name,or take her dog walking due to extreme pain in her arm. Says she has applied cold and warm compresses with no relief.
chills, slight fever, overall drowsiness, lack of appetite These symptoms woke me up many times overnight the night of the shot. It's been about 24 hours now, and a long nap has lessened them, but my head still hurts.
Immunization information systems shows patient completed Moderna primary series on 08/26/21, MOderna Booster inadvertently administered on 01/12/22, two weeks before the 5 month interval.
woke on 1/9/2021 with a cold sore on lt side of upper lip. Treated with topical Denivir ointment as I have before. By 12Noon, I noticed my left upper lip had swollen quite a bit, and then then swelling progressed across my entire upper lip, and then outward to my bilateral cheeks, and upward to my nasal area and to my bilateral orbits. My left side was worse then my right. the progression occurred over the course of Jan 9th and again Jan 10th, but as it progressed outward, it subsided slowly from where it started (my upper lip)
Shingles; stabbing pain; itching; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 7 days after receiving Shingles vaccine, the patient experienced shingles, pain and pruritus. On an unknown date, the outcome of the shingles was unknown and the outcome of the pain and pruritus were not recovered/not resolved.   It was unknown if the reporter considered the shingles, pain and pruritus to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had the shot and got shingles a week later. That was 4 years ago, to this day he/she had stabbing pains and itching on the shingles site. The follow up would not possible as no contact details were available.
Pt recvd 3 doses of Engerix-B 4JAN90, 7FEB90 & 6JUL90 & AUG91 titers tested & it was discovered that the pt did not convert antibody;
dizziness; vertigo; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) and VERTIGO (vertigo) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE] for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced DIZZINESS (dizziness) and VERTIGO (vertigo). At the time of the report, DIZZINESS (dizziness) and VERTIGO (vertigo) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient took more water as treatment.   This case was linked to US-MODERNATX, INC.-MOD-2021-073850 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Additional info-2 : To confirm NNI; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073850:Patient's friend case
has them right now and had the vaccine/suspected vaccination failure; has them/ still got them (shingles); there driving him crazy,so painful; This case was reported by a consumer via interactive digital media and described the occurrence of Suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and pain were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional details were reported as follows: This case was reported by the patient's child. The age at vaccination was not reported. The patient had the Shingle vaccine and got shingles and at the time of reporting he still had shingles and there driving him crazy and it was so painful. The follow up would not possible as contact information was not available. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation for shingles were not provided.
PATIENT STATES THAT SINCE THE INJECTION HE HAS HAD SEVERE PAIN RUNNING DOWN HIS LEFT UPPER ARM FROM THE INJECTION SITE. STATES THAT THE INJECTION WAS GIVEN HIGH ON HIS ARM.  HE WENT TO A PHYSICIAN TO BE CHECK OUT.
Patient received HPV injection. When she went out to the waiting room she stated she began to feel faint.  Her boyfriend helped her to a chair where she passed out.  She was transported via wheel chair to observation room.  Vital signs were taken.  They were stable.  Pt was lain in bed.  7-up given to drink.  Cold washcloth applied to face. After 15-20 minutes, pt. stated she felt fine now.  Vital signs were retaken.  All were stable.  Pt. discharged to home.
I am a nurse and received the Moderna COVID19 vaccine as part of my facility's COVID clinic. CVS Pharmacy staff came to my facility to administer vaccines to staff and residents. Pharmacist notified of my reaction and recommended reporting on this website as listed on fact sheet provided. I had mild tingling  to bilateral hands and arms  within 2 minutes of vaccine administration and it lasted approximately 20 minutes, then subsided. VS monitored by nursing staff and WNL.  No tachycardia or respiratory distress.
Fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and MYALGIA (Body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced PYREXIA (Fever) and MYALGIA (Body aches). At the time of the report, PYREXIA (Fever) and MYALGIA (Body aches) outcome was unknown. Not Provided          Concomitant drug details not provided. Treatment details not provided.
Vaccines administered in clinic around 9:15AM on 12/8/22 Parents first noted tactile fever at home around 1PM and gave tylenol Grandmother checked axillary temp at home at 5 PM and was noted to be 100.9, second dose of tylenol was given Mother returned from work after and he felt very hot to touch, so was taken to the local ER due to fever and he had a rectal temperature of 103.4 around 9PM.  Received a dose of ibuprofen and within a few minutes began having seizure activity while in the ER and observed by ER staff/RNs.  Seizure was brief, whole body.  Had a period of fatigue after, but was able to awaken and take a bottle before discharge from the ER at 1AM on 12/9/22
Engerix 10 mcg instead 20 mcg administered; 23 YO was administered  Engerix Pediatric dose; This case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 23-year-old female patient who received HBV (Engerix B pediatric) (batch number LP724, expiry date 18th May 2023) for prophylaxis.   On 5th July 2022, the patient received the 1st dose of Engerix B pediatric. On 5th July 2022, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.  Additional Information: GSK Receipt Date: 05-AUG-2022 Reporter's Comments: The patient administered a Engerix Pediatric dose (10 mcg). On 5th August 2022, the patient received second adult dose (20 mcg). The reporter asked how to proceed with the series and did patient need to restart series. No additional details provided.  The reporter did not consent to follow-up. Additional Supportive Information: The adult patient received a dose of Engerix B pediatric instead of Engerix B adult, which led to underdose and adult use of a child product.
6/4/99 noted to have isolated areas of raised papules, red approx 30 over entire body, no fever, otherwise appears well;MMR given 5/25/99;
Client sat after shot for monitoring and began feeling light headed, so we held him in the chair and he lost consciousness for a few swconds and became diaphoretic, atvwhich point i called 911. When the patient became conscious, we helped him to lie down and elevated his feet while awaiting the EMS. Bp was 120/80 , pulse 63, and o2 sat was 98% on open air. EMS arrived on scene about 7:30 pm, and patient was turned over to their care. Patient was stabilized, and declined transfer, and was alert, and able to leave under his own power with his partner at 8:05 pm.
Swelling  in knees, pain - ibuprofen, ice, super CBD Dragon Balm Cortisone shot in knee, naproxen, biofreeze - pain relieved for 2 weeks Physical therapy - 8 sessions - relief of pain
Rash; swelling around the eyes; sleepy; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in April 2019, refer linked case US2020AMR000600).   On 24th September 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced rash, periocular swelling and sleepiness. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the rash, periocular swelling and sleepiness were unknown.   It was unknown if the reporter considered the rash, periocular swelling and sleepiness to be related to Shingrix.  Additional details were provided as follows: The batch number and expiration dates were not provided as the patient received the vaccine in another facility. The patient that received the 2nd dose of Shingrix and experienced rash, swelling around the eyes and felt sleepy. The reporter requested information about how to proceed. The reporter to follow up.
SEVERE breathing difficulty and EXTREME fatigue to the point of needing emergency medical care but can?t afford it so...
left upper arm at site of vaccination with 3-4 cm circular indurated erythematous swelling with no significant tenderness, fluctuance or surrounding edema.
Headache, runny nose, fatigue, body aches. Treated with Alleve, Mucinex and sleep.
This spontaneous report as received from a medical assistant on 13-NOV-2014 refers to an unknown number of patients of unknown age and gender. On an unknown date the patients were vaccinated with a dose of ROTATEQ (strength, dose and lot# were unknown) which underwent a supported temperature excursion, oral. No adverse effects were reported. Additional information has been requested.
Myalgia, Fever, flu like for 4 day Narrative:  Other Relevant History:
Pt. left voicemail this AM of 10-04-12 that after receiving flu vaccine on 10-03-13 at 08:30, she bean to feel constriction in her throat, used inhaler to reduce constriction. At 6 PM that day she had a fever of 100.6 orally, cough, ears felt plugged and irritated, and headache. Only took Nyquil to alleviate sx. 10/03/13 - Today only headache remains at 12:00 PM.
Narrative:  About an hour after injection, patient developed redness all over and itching. Was given oral Benadryl.
**16 Weeks pregnant,. Due date September 2021. 1st pregnancy.  I got the vaccine about 5:40pm-6pm. I started feeling tired and had chills. The next morning I couldn't move my arm at all, it was sore soar and I had chills, multiple blankets on and still feeling the chills. I had a massive headaches, I had a little bit of cramping. I ended up going to the Urgent Care. They check the baby's heart beat and check for UTI. All test came back negative and found the baby heart beat. I went home and took a Tylenol. I went in to see my OB and had a check up and everything is ok. The chills lasted about 48 hours, my arm was sore for several days.
Pt received vax @1014 and was released at 1029. Pt returned stating swallowing tongue, EMS on site called , @ 1104 Pt stated feeling much better and no noticeable signs of pt swallong tongue during this period. 1110- No symptoms reported by patient and patient released.
Expired vaccine beyond MFG Exp. Date administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine beyond MFG Exp. Date administered) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine beyond MFG Exp. Date administered). On 13-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine beyond MFG Exp. Date administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided  The reporter stated that only Lot # 001C21A was used to inject 7 people beyond the manufacturer expiration date on 13 & 14th OCT2021 (Lot# 001C21A & MFG Exp. Date: 12OCT2021). The reporter stated that she does not think that any were pregnant because of their age. The reporter also stated that she thinks that it was the second dose for all recipients but was not sure.   This case was linked to MOD-2021-354610 (Patient Link).
Mom reports pt had increasing emotional and balance problems. He was combative and "challenging" per mom. He has been crying with sadness.
chills; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and VOMITING (vomiting) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced CHILLS (chills) and VOMITING (vomiting). On 14-Mar-2021, CHILLS (chills) and VOMITING (vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Pyrexia: 101f (High) 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information provided.  No treatment information given.